Consumption of new psychoactive substances in a Spanish sample of research chemical users

Human Psychopharmacology

Volumn 28, Issue 4, 2013, Pages 332-340

  González, Débora ^a,b   Ventura, Mireia ^c   Caudevilla, Fernando ^d   Torrens, Marta ^a,b   Farre, Magi ^a,b  

^a HOSPITAL DEL MAR   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c Asociacion Bienestar y Desarrollo   (Spain)

^d Centro de Salud Puerta Bonita i   (Spain)

Author keywords

2C B; consumption patterns; new psychoactive substances; research chemicals

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; 4 HYDROXYBUTYRIC ACID; 4' METHYLMETHCATHINONE; AMPHETAMINE; CANNABIS; CATHINONE; COCAINE; CODEINE; DIAMORPHINE; EPHEDRINE; HOMOVERATRYLAMINE; IBOGAINE; KETAMINE; LYSERGIDE; MESCALINE; METHADONE; METHAMPHETAMINE; METHYLERGOMETRINE; METHYLONE; METHYLPHENIDATE; MORPHINE; NITROUS OXIDE; OPIATE; PHENETHYLAMINE DERIVATIVE; PSILOCYBINE; PSYCHOTROPIC AGENT;

ACCURACY; ADULT; CONFERENCE PAPER; CROSS-SECTIONAL STUDY; FEMALE; HUMAN; INFORMATION RETRIEVAL; INTERNET; INTERVIEW; MAJOR CLINICAL STUDY; MALE; ORGANIZATION; PREVALENCE; PREVENTION; PRIORITY JOURNAL; RISK; RISK REDUCTION; SALVIA DIVINORUM; SPAIN; SUBSTANCE ABUSE;

2C-B; CONSUMPTION PATTERNS; NEW PSYCHOACTIVE SUBSTANCES; RESEARCH CHEMICALS;

ADOLESCENT; ADULT; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; PSYCHOTROPIC DRUGS; RISK REDUCTION BEHAVIOR; SPAIN; STREET DRUGS; SUBSTANCE-RELATED DISORDERS; YOUNG ADULT;

EID: 84880793408     PISSN: 08856222     EISSN: 10991077     Source Type: Journal    
DOI: 10.1002/hup.2323     Document Type: Conference Paper

References (43)

1. ACMD, 2010. Report on the consideration of the cathinones. Advisory Council on the Misuse of Drugs.
2. Archer RP, Treble R, Williams K,. 2011. Reference materials for new psychoactive substances. Drug Test Anal 3: 505-514.
3. Ayres TC, Bond JW,. 2012. A chemical analysis examining the pharmacology of novel psychoactive substances freely available over the Internet and their impact on public (ill)health. Legal highs or illegal highs? BMJ Open 2: e000977.
4. Baron M, Elie M, Elie L,. 2011. An analysis of legal highs: do they contain what it says on the tin? Drug Test Anal 3: 576-581.
5. Bruno R, Matthews AJ, Dunn M, et al,. 2012. Emerging psychoactive substance use among regular ecstasy users in Australia. Drug Alcohol Depend 124: 19-25.
6. Brunt TM, Poortman A, Niesink RJ, van den Brink W,. 2011. Instability of the ecstasy market and a new kid on the block: mephedrone. J Psychopharmacol 25: 1543-1547.
7. Butler SF, Venuti SW, Benoit C, Beaulaurier RL, Houle B, Katz N,. 2007. Internet surveillance: content analysis and monitoring of product-specific internet prescription opioid abuse-related postings. Clin J Pain 23: 619-628.
8. Caudevilla-Galligo F, Riba J, Ventura M, et al,. 2012. 4-Bromo-2,5-dimethoxyphenethylamine (2C-B): presence in the recreational drug market in Spain, pattern of use and subjective effects. J Psychopharmacol 26: 1026-1035.
9. Cone EJ,. Ephemeral profiles of prescription drug and formulation tampering: evolving pseudoscience on the Internet. 2006. Drug Alcohol Depend 83: 31-39.
10. Corazza O, Demetrovics Z, van den Brink W, Schifano F,. 2012. 'Legal Highs' an inappropriate term for 'Novel Psychoactive Drugs' in drug prevention and scientific debate. Int J Drug Policy 24: 82-83.
11. Davey Z, Schifano F, Corazza O, Deluca P,. 2012. Psychonaut Web Mapping Group. e-Psychonauts: conducting research in online drug forum communities. J Ment Health 21: 386-394.
12. Davies S, Wood DM, Smith G, et al,. 2010. Purchasing 'legal highs' on the Internet-is there consistency in what you get? QJM 103: 489-493.
13. Deluca P, Davey Z, Corazza O, et al,. 2012. Identifying emerging trends in recreational drug use; outcomes from the Psychonaut Web Mapping Project. Prog Neuropsychopharmacol Biol Psychiatry 39: 221-226.
14. EMCDDA. 2004. Report on risk assessment of 2C-I, 2C-T-2 and 2C-T-7 in the framework of the Joint Action on New Synthetic Drugs and Drug Addiction. European Monitoring Centre for Drugs and Drugs Addiction.
15. EMCDDA, 2010. Annual report on the state of the drugs problem in Europe. European Monitoring Centre for Drug Addiction.
16. EMCDDA, 2012. Annual report on the state of the drugs problem in Europe. European Monitoring Centre for Drugs and Drugs Addiction.
17. Energy control, 2011. Análisis de sustancias. Tablas de pastillas. Retrieved June 2, 2012, from: http://energycontrol.org/analisis-de-sustancias/ resultados/tablas-de-pastillas.html.
18. Fattore L, Fratta W,. 2011. Beyond THC: the new generation of cannabinoid designer drugs. Front Behav Neurosci 5: 60.
19. Fernández-Calderón F, Lozano OM, Vidal C, et al,. 2011. Polysubstance use pattern in underground rave attenders: a cluster analysis. J Drug Educ 41: 183-202.
20. González D, Riba J, Bouso JC, Gómez-Jarabo G, Barbanoj MJ,. 2006. Pattern of use and subjective effects of Salvia divinorum among recreational users. Drug Alcohol Depend 85: 157-162.
21. Grov C, Kelly BC, Parsons JT,. 2009. Polydrug use among club-going young adults recruited through time-space sampling. Subst Use Misuse 44: 848-864.
22. Instituto Nacional de Estadística. 2010. Indicadores sociales. Retrieved 2 Junio, 2012 from: http://www.ine.es/buscar/searchResults.do? searchType=DEF-SEARCH&tipoDocumento=&searchString= nivel+educativo+poblaci%F3n&SearchButton=Buscar.
23. Instituto Nacional de Estadística. 2011. Encuesta sobre población activa. Retrieved 2 Junio, 2012 from: http://www.ine.es/jaxi/ tabla.do?per=03&type=db&divi=EPA&idtab=11&L=0.
24. Lea T, Reynolds R, De Wit J,. 2011. Mephedrone use among same-sex attracted young people in Sydney, Australia. Drug Alcohol Rev 30: 438-440.
25. Logan BK, Reinhold LE, Xu A, Diamond FX,. 2012. Identification of synthetic cannabinoids in herbal incense blends in the United States. J Forensic Sci 57: 1168-1180.
26. McCambridge J, Mitcheson L, Winstock A, Hunt N,. 2005. Five-year trends in patterns of drug use among people who use stimulants in dance contexts in the United Kingdom. Addiction 100: 1140-1149.
27. Measham F, Moore K, Newcombe R, Welch Z,. 2010. Tweaking, bombing, dabbing, and stockpiling: the emergence of mephedrone and the perversity of prohibition. Drugs Alcohol Today 10: 14-21.
28. MSC. 2002a. Orden SCO/2359/2004, de 2 de julio. BOE 171, 16 de julio del 2003. Retrieved June 2, 2012, from: http://www.boe.es/boe/dias/2004/07/16/pdfs/ A25980-25981.pdf.
29. MSC. 2002b. Orden SCO/469/2002, de 19 de febrero. BOE 56, 6 Marzo del 2002. Retrieved June 2, 2012, from: http://www.boe.es/boe/dias/2002/03/06/pdfs/ A09119-09121.pdf.
30. MSC. 2011. Orden SPI/201/2011de 3 de febrero, BOE 34, 9 Febrero del 11. Retrieved June 2, 2012, from: http://boe.es/diario-boe/txt.php?id=BOE-A-2011- 2490.
31. PNSD. 2011. Encuesta sobre alcohol y drogas en población general en España. EDADES 2011-2012. Retrieved April 8, 2013, from: http://www.pnsd.msc.es/Categoria2/observa/pdf/EDADES2011.pdf
32. Ramsey J, Dargan PI, Smyllie M, et al,. 2010 Buying 'legal' recreational drugs does not mean that you are not breaking the law. QJM 103: 777-783.
33. Russell MJ, Bogun B,. 2011. New "party pill components in New Zealand: the synthesis and analysis of some β-ketone analogues of 3,4-methylenedioxymethamphetamine (MDMA) including βk-DMBDB (β-ketone-N,N-dimethyl-1-(1,3-benzodioxol-5-yl)-2-butanamine). Forensic Sci Int 210: 174-181.
34. Sanders B, Lankenau SE, Bloom JJ, Hathazi D,. 2008. "Research chemicals": tryptamine and phenethylamine use among high-risk youth. Subst Use Misuse 43: 389-402.
35. Schifano F, Deluca P, Agosti L, et al,. 2005. New trends in the cyber and street market of recreational drugs? The case of 2C-T-7 ('Blue Mystic'. J Psychopharmacol 19: 675-679
36. Schifano F, Deluca P, Baldacchino A, et al,. 2006. Drugs on the web; the Psychonaut 2002 EU project. Prog Neuropsychopharmacol Biol Psychiatry 30: 640-646.
37. Schifano F, Corazza O, Deluca P, et al,. 2009. Psychoactive drug or mystical incense? Overview of the online available information on Spice products. Int J Culture and Mental Health 2: 137-144.
38. Van Hout MC, Brenan R,. 2012. Curiosity killed M-Cat: a post-legislative study on mephedrone use in Ireland. Drugs: Educ Prev Policy 19: 156-162.
39. Vardakou I, Pistos C, Spiliopoulou C,. 2010. Spice drugs as a new trend: mode of action, identification and legislation. Toxicol Lett 197: 157-162.
40. Winstock A, Mitcheson L, Marsden J,. 2010a. Mephedrone: still available and twice the price. Lancet 376: 1537.
41. Winstock AR, Marsden J, Mitcheson L,. 2010b. What should be done about mephedrone? BMJ 23: 340.
42. Winstock AR, Mitcheson LR, Deluca P, Davey Z, Corazza O, Schifano F,. 2011. Mephedrone, new kid for the chop? Addiction 106: 154-161.
43. Zukiewicz-Sobczak W, Zwoliński J, Chmielewska-Badora J, et al,. 2012. Analysis of psychoactive and intoxicating substances in legal highs. Ann Agric Environ Med 19: 309-314.